Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-16

Clinical Trial Update: Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia. [Phase 3]

View source ↗

Summary

Phase 3 trial update on DYSPORT using a 2 mL dilution in adults with cervical dystonia reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED | Results posted: 2017-03-16